NCT00002587View on ClinicalTrials.gov

Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 1994

Primary Completion Date

December 31, 2000

Study Completion Date

December 31, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH